WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 44 filers reported holding WEREWOLF THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,119,006 | -29.8% | 522,900 | 0.0% | 0.01% | -22.2% |
| Q2 2023 | $1,594,845 | +17.3% | 522,900 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $1,359,540 | +26.8% | 522,900 | 0.0% | 0.01% | +80.0% |
| Q4 2022 | $1,071,945 | -54.5% | 522,900 | 0.0% | 0.01% | -64.3% |
| Q3 2022 | $2,358,000 | +7.7% | 522,900 | -2.3% | 0.01% | -58.8% |
| Q2 2022 | $2,189,000 | – | 535,160 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $2,592,000 | 33.68% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $18,850,000 | 6.44% |
| MPM BioImpact LLC | 2,388,011 | $10,507,000 | 2.82% |
| RA Capital Management | 4,291,881 | $18,884,000 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 584,203 | $2,570,000 | 0.36% |
| PFM Health Sciences, LP | 585,327 | $2,575,000 | 0.10% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 958,125 | $4,216,000 | 0.09% |
| Granite Point Capital Management, L.P. | 55,000 | $242,000 | 0.05% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 213,381 | $939,000 | 0.03% |
| CAAS CAPITAL MANAGEMENT LP | 101,595 | $447,000 | 0.02% |